Pepin F, Niederer RL. Re: Leclercq et al.: Anti-tumor necrosis factoralpha versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French Uveitis Network. (Ophthalmology. 2021 Nov 16;S0161-6420(21)00900-3. doi: 10.1016/j.ophtha Ophthalmology 2022 Mar 24. pii: S0161-6420(22)00158.
PMID: 35346510